Citadel Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $302K | Sell |
|
|||||
|
2025
Q2 | $218K | Buy |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.86K | Sell |
|
|||||
|
2024
Q1 | $58.6K | Buy |
|
|||||
|
2023
Q4 | $11.6K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $616 | Sell |
|
|||||
|
2023
Q1 | $2.68K | Sell |
|
|||||
|
2022
Q4 | $94.5K | Buy |
|
|||||
|
2022
Q3 | $29K | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $90K | Buy |
|
|||||
|
2021
Q3 | $95K | Buy |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $43K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $47K | Sell |
|
|||||
|
2020
Q1 | $101K | Buy |
|
|||||
|
2019
Q4 | $32K | Sell |
|
|||||
|
2019
Q3 | $70K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $104K | Sell |
|
|||||
|
2018
Q4 | $71K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $149K | Sell |
|
|||||
|
2018
Q1 | $320K | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $33K | Sell |
|
|||||
|
2017
Q1 | $80K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $29K | Buy |
|
|||||
|
2016
Q2 | $20K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $21K | Sell |
|
|||||
|
2015
Q2 | $29K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $24K | Sell |
|
|||||
|
2014
Q3 | $101K | Buy |
|
|||||
|
2014
Q2 | $37K | Buy |
|
|||||
|
2014
Q1 | – | Hold |
|